Occam Places Chief Legal Officer at Public Oncology Biotech
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company focused on the development and commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic malignancies. In August 2023, Occam placed Scott Samuels as SVP, Chief Legal Officer, and Corporate Secretary.
Prior to Geron, Scott served as Chief Legal and Compliance Officer of clinical-stage biotech, Prilenia Therapeutics. He was formerly the founding General Counsel of BeiGene, where he strategically built the company’s legal and compliance functions. Scott began his operating career at ARIAD after 17 years spent in the corporate and life sciences practices of Mintz Levin. Scott holds a J.D. from George Mason University and a B.A. in philosophy from Cornell University.
Geron is a longstanding client for whom Occam has previously placed three independent Board members, John, McDonald, Dawn Bir, and Liz O'Farrell, and more recently, Chief Business Officer Edward Koval and VP Investor Relations & Corporate Communications Aron Feingold.
Related Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.